第60回日本神経学会学術大会

セッション情報

印刷

シンポジウム

[S-04] Update on Diagnostic Biomarkers for the early diagnosis of Alzheimer's Disease

2019年5月22日(水) 13:20 〜 15:20 第1会場 (大阪国際会議場5F 大ホール)

座長：岩坪 威（東京大学大学院医学系神経病理学）, 古和 久朋（神戸大学大学院保健学研究科リハビリテーション科学領域）

In recent advance of Alzheimer research field, development of tau imaging　and novel plasma biomarkers provide new prospect of clinical research and drug development. In this symposium, four presentators will be presenting and discussing on diagnostic biomarkers and their impacts on the diagnosis of Alzheimer's disease.

[S-04-1] タウ病変PETイメージングのアップデート

樋口 真人 (量子科学技術研究開発機構)

In recent advance of Alzheimer research field, development of tau imaging　and novel plasma biomarkers provide new prospect of clinical research and drug development. In this symposium, four presentators will be presenting and discussing on diagnostic biomarkers and their impacts on the diagnosis of Alzheimer's disease.

[S-04-2] アルツハイマー病バイオマーカーとしての血漿中アミロイドβ

田中 耕一 (株式会社 島津製作所　田中耕一記念質量分析研究所)

In recent advance of Alzheimer research field, development of tau imaging　and novel plasma biomarkers provide new prospect of clinical research and drug development. In this symposium, four presentators will be presenting and discussing on diagnostic biomarkers and their impacts on the diagnosis of Alzheimer's disease.

[S-04-3] TRC-PAD: Accelerating Recruitment in AD Clinical Trials via Innovation in Information Technology

Gustavo A. Jimenez-Maggiora1, Rema Raman1, Michael S. Rafii1, Reisa A. Sperling2,3, Jeffrey L. Cummings4, Paul S. Aisen1 (1.Alzheimer's Therapeutics Research Institute, University of Southern California, USA, 2.Department of Neurology, Massachusetts General Hospital, Harvard Medical School, USA, 3.Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital, Harvard Medical School, USA, 4.Cleveland Clinic Lou Ruvo Center for Brain Health, USA)

In recent advance of Alzheimer research field, development of tau imaging　and novel plasma biomarkers provide new prospect of clinical research and drug development. In this symposium, four presentators will be presenting and discussing on diagnostic biomarkers and their impacts on the diagnosis of Alzheimer's disease.

[S-04-4] Japanese ADNI: バイオマーカーから疾患修飾療法へ

岩坪 威 (東京大学大学院医学系研究科 神経病理学)

In recent advance of Alzheimer research field, development of tau imaging　and novel plasma biomarkers provide new prospect of clinical research and drug development. In this symposium, four presentators will be presenting and discussing on diagnostic biomarkers and their impacts on the diagnosis of Alzheimer's disease.